e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Published

Drug Resistance Against Antimalarial Drugs

Published in January 2017 Issue 1 (Vol. 5, Issue 1, 2017)

Drug Resistance Against Antimalarial Drugs - Issue cover

Abstract

In this short communication, we have discussed about killer disease malaria and drug resistance caused by many popular drugs. Malaria is oldest and very important parasitic disease in mankind from ancient times. Millions of people are at high risk of this disease every year. This disease has become major cause of morbidity and mortality in this world because of emergence of resistance to first line drugs. Because of development of resistance of old drug molecules and therapies, WHO recommends combination therapies for the treatment of malaria. This short communication will highlight the reason of resistance along with new findings of molecules against resistance developed molecules in the market. Artemisinin combination therapies are first line treatment for all Plasmodium falciparum parasites in malaria endemic countries of the world according to WHO recommendations. Malaria eradication will become a battle in the world with urgent need of new drug molecule or therapy to combat against this disease leading to effective global malaria control programme.

Authors (3)

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPHR501004

AJPHR-50-000004

2017-01-01

Article Impact

Views:1,415
Downloads:1,888

How to Cite

APA
MLA
Chicago
Harvard
Vancouver
IEEE
ACM
ACS
ABNT
Turabian
RIS (EndNote/Zotero/Mendeley)
BibTeX

Kalra & Diwan & Sharma (2017). Drug Resistance Against Antimalarial Drugs. American Journal of Pharmacy and Health Research, 5(1), xx-xx. https://ajphr.com/articles/AJPHR501004

Article Actions